BRIEF-Nrx Pharmaceuticals Files Abbreviated New Drug Application (ANDA) For Preservative-Free Iv Ketamine

Reuters
05 Jun
BRIEF-Nrx Pharmaceuticals Files Abbreviated New Drug Application (ANDA) For Preservative-Free Iv Ketamine

June 5 (Reuters) - NRX Pharmaceuticals Inc NRXP.O:

  • NRX PHARMACEUTICALS, INC. $(NRXP)$ FILES ABBREVIATED NEW DRUG APPLICATION (ANDA) FOR PRESERVATIVE-FREE IV KETAMINE

  • NRX PHARMACEUTICALS INC - ANTICIPATES PRIORITY REVIEW DUE TO KETAMINE SHORTAGE

  • NRX PHARMACEUTICALS INC - NDA SUBMISSION FOR NRX-100 IN SUICIDAL DEPRESSION, PDUFA EXPECTED LATE 2025

Source text: ID:nPn1NKFmFa

Further company coverage: NRXP.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10